aTyr Pharma, Inc. (ATYR)
0.7799
-0.01
(-1.73%)
USD |
NASDAQ |
Apr 29, 09:48
aTyr Pharma Research and Development Expense (TTM) : 60.22M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Liquidia Corp. | 38.35M |
| Agenus, Inc. | 79.34M |
| Curis, Inc. | 28.25M |
| LadRx Corp. | 0.7712M |
| Plus Therapeutics, Inc. | 8.379M |